These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease. Rusz J; Cmejla R; Ruzickova H; Ruzicka E J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016 [TBL] [Abstract][Full Text] [Related]
10. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease. Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781 [TBL] [Abstract][Full Text] [Related]
11. Speech difficulties in early de novo patients with Parkinson's disease. Polychronis S; Niccolini F; Pagano G; Yousaf T; Politis M Parkinsonism Relat Disord; 2019 Jul; 64():256-261. PubMed ID: 31078401 [TBL] [Abstract][Full Text] [Related]
12. Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease. Tykalova T; Novotny M; Ruzicka E; Dusek P; Rusz J NPJ Parkinsons Dis; 2022 Mar; 8(1):22. PubMed ID: 35256614 [TBL] [Abstract][Full Text] [Related]
13. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder? Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy. Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E J Neural Transm (Vienna); 2013 Feb; 120(2):319-29. PubMed ID: 22772465 [TBL] [Abstract][Full Text] [Related]
15. Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients. Hirata K; Hattori T; Kina S; Chen Q; Ohara M; Yokota T Mov Disord; 2020 Jun; 35(6):1037-1045. PubMed ID: 32163636 [TBL] [Abstract][Full Text] [Related]
16. Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation. Brabenec L; Mekyska J; Galaz Z; Rektorova I J Neural Transm (Vienna); 2017 Mar; 124(3):303-334. PubMed ID: 28101650 [TBL] [Abstract][Full Text] [Related]
17. Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study. Mračková M; Mareček R; Mekyska J; Košťálová M; Rektorová I J Neural Transm (Vienna); 2024 Feb; 131(2):181-187. PubMed ID: 37943390 [TBL] [Abstract][Full Text] [Related]
18. Aspects of speech rate and regularity in Parkinson's disease. Skodda S J Neurol Sci; 2011 Nov; 310(1-2):231-6. PubMed ID: 21849174 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic Correlates of Orthostatic Hypotension in de novo Parkinson's Disease. Umehara T; Oka H; Nakahara A; Shiraishi T; Sato T; Matsuno H; Komatsu T; Omoto S; Murakami H; Iguchi Y J Parkinsons Dis; 2021; 11(2):665-673. PubMed ID: 33361609 [TBL] [Abstract][Full Text] [Related]
20. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task. Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]